Cash Flow Harmony Biosciences Holdings, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
215.00
191.00
173.00
104.00
37.00
-36.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
91.00
-7.00
35.00
-4.00
0.00
-11.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
348.00
219.00
219.00
144.00
98.00
-2.00
Cash Flow from Investing Activities
-39.00
-67.00
-46.00
-141.00
-100.00
-2.00
Cash Flow from Financing Activities
-9.00
-10.00
-105.00
6.00
7.00
209.00
Net Cash Inflow / Outflow
299.00
141.00
67.00
9.00
5.00
204.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Harmony Biosciences Holdings, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
215.064
-344.894000000368
559.00
162.36%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
91.817
4.36000000000465
87.00
2005.89%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
348.199
-279.118000000297
627.00
224.75%
Cash Flow from Investing Activities
-39.649
217.998000000232
-256.00
-118.19%
Cash Flow from Financing Activities
-9.049
117.113000000125
-126.00
-107.73%
Net Cash Inflow / Outflow
299.501
56.4510000000602
243.00
430.55%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0.458000000000488
0.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 58.40% vs 0.20% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
348.20
219.82
58.40%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
